VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VANI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VANIVivani Medical, Inc.
$1.35$80M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVANIQuarterly Financials

Vivani Medical, Inc. (VANI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Vivani Medical, Inc. (VANI) quarterly income statement — complete revenue, gross profit & net income history

VANI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold130K000089K00098K0000000000
COGS % of Revenue--------------------
Gross Profit-130K0000-89K000-98K0000000000
Gross Margin %--------------------
Gross Profit Growth %-100%---9.18%-----------100%-100%
Operating Expenses6.69M6.81M6.72M7.46M6.56M6.37M6.31M5.68M6.23M6.12M7.14M7M6.6M7.79M5.44M4.09M3.91M3.55M3.48M3.31M
OpEx % of Revenue--------------------
Selling, General & Admin2.43M2.18M2.21M2.7M2.34M2.07M2.11M2.17M2.5M1.41M2.7M3.14M2.65M1.66M1.58M884K1.23M573K617K555K
SG&A % of Revenue--------------------
Research & Development4.26M4.63M4.52M4.76M4.22M4.3M4.2M3.51M3.73M4.71M4.44M3.86M3.96M4.43M3.86M3.2M2.68M2.98M2.87M2.75M
R&D % of Revenue--------------------
Other Operating Expenses00000000000001000K000000
Operating Income-6.82M-6.81M-6.72M-7.46M-6.56M-6.46M-6.31M-5.68M-6.23M-6.22M-7.14M-7M-6.6M-7.79M-5.44M-4.09M-3.91M-3.55M-3.48M-3.31M
Operating Margin %--------------------
Operating Income Growth %-3.97%-5.42%-6.59%-31.35%-5.3%-3.91%11.69%18.88%5.67%20.19%-31.23%-71.35%-68.95%-119.56%-56.21%-23.55%-31.33%-178.49%-117.54%-45.86%
EBITDA-6.69M-6.7M-6.62M-7.36M-6.46M-6.37M-6.2M-5.58M-6.13M-6.12M-7.07M-6.92M-6.49M-7.68M-5.34M-4M-3.82M-3.46M-3.4M-3.22M
EBITDA Margin %--------------------
EBITDA Growth %-3.59%-5.09%-6.83%-31.88%-5.34%-4.12%12.39%19.38%5.62%20.33%-32.38%-73.08%-69.8%-121.65%-57.33%-24.11%-32.46%-175.44%-114.94%-43.37%
D&A (Non-Cash Add-back)130K115K105K102K102K89K112K100K99K98K71K80K108K110K101K87K83K83K89K85K
EBIT-6.82M-6.81M-6.72M-7.46M-6.56M-6.05M-6.31M-5.68M-6.23M-6.03M-7.14M-7M-6.6M-6.09M-5.44M-4.09M-3.91M-3.55M-3.48M-3.31M
Net Interest Income00000000000000000002K
Interest Income00000000000000000002K
Interest Expense00000000000000000000
Other Income/Expense37K177K195K318K255K410K268K325K188K191K362K477K283K506K6.87M-16K-17K-72K-6K633K
Pretax Income-6.78M-6.63M-6.53M-7.14M-6.3M-6.05M-6.04M-5.36M-6.04M-6.03M-6.78M-6.53M-6.32M-7.28M1.42M-4.1M-3.92M-3.62M-3.49M-2.67M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-6.78M-6.63M-6.53M-7.14M-6.3M-6.05M-6.04M-5.36M-6.04M-6.03M-6.78M-6.53M-6.32M-7.28M1.42M-4.1M-3.92M-3.62M-3.49M-2.67M
Net Margin %--------------------
Net Income Growth %-7.58%-9.64%-8.09%-33.38%-4.35%-0.4%10.93%17.93%4.42%17.27%-576.6%-59.05%-61.01%-101.22%140.76%-53.38%-31.37%-180.4%-117.78%13.71%
Net Income (Continuing)-6.78M-6.63M-6.53M-7.14M-6.3M-6.05M-6.04M-5.36M-6.04M-6.03M-6.78M-6.53M-6.32M-7.28M1.42M-4.1M-3.92M-3.62M-3.49M-2.67M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.08-0.09-0.11-0.12-0.11-0.11-0.11-0.10-0.12-0.12-0.13-0.13-0.12-0.130.22-0.08-0.12-0.09-0.11-0.08
EPS Growth %27.27%18.18%0%-23.33%8.33%8.33%15.38%25.15%0%7.69%-159.09%-60.1%0%-41.46%300%-1.5%-32.89%-64.7%-58.73%46.67%
EPS (Basic)-0.08-0.09-0.11-0.12-0.11-0.11-0.11-0.10-0.12-0.12-0.13-0.13-0.12-0.130.22-0.08-0.12-0.09-0.11-0.08
Diluted Shares Outstanding81.27M62.39M59.71M59.24M59.24M57.42M55.25M55.02M52.2M51.02M50.84M50.8M50.76M50.74M38.48M50.73M33.09M39.41M33.09M28.67M
Basic Shares Outstanding81.27M62.39M59.71M59.24M59.24M57.42M55.25M55.02M52.2M51.02M50.84M50.8M50.76M50.74M37.97M50.73M33.09M39.41M33.09M28.67M
Dividend Payout Ratio--------------------